NCT03011814 · Interventional trial
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Overall registry status Recruiting
Phase 1 · Phase 2
Conditions Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides, Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Mycosis Fungoides, Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified, Sezary Syndrome
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County · Withdrawn
First posted
Registry updated
Added to the directory